세계의 마우스 모델 시장 : 서비스, 유형, 기술, 용도별 - 예측(2023-2030년)

The Global Mice Model Market is forecasted to grow significantly, with a projected USD 1,449.44 million in 2023 at a CAGR of 8.31% and expected to reach a staggering USD 2,540.26 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Mice Model Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Mice Model Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Service, market is studied across Breeding, Cryopreservation, Genetic Testing, Model In-Licensing, and Quarantine. The Breeding commanded largest market share of 30.30% in 2022, followed by Genetic Testing.

Based on Type, market is studied across Conditioned/Surgically Modified Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Inbred Mice, and Outbred Mice. The Conditioned/Surgically Modified Mice commanded largest market share of 27.26% in 2022, followed by Genetically Engineered Mice.

Based on Technology, market is studied across CRISPER, Embryonic Stem Cell Injection, Genetically Modified Sperm-Mediated Gene Transfer, Liposome-Mediated DNA & Electroporation of DNA, Microinjection, Nuclear Transfer, and TALENs & ZFNs. The Nuclear Transfer commanded largest market share of 23.48% in 2022, followed by Microinjection.

Based on Application, market is studied across Cardiovascular Studies, Central Nervous System Studies, Diabetes Studies, Immunology & Inflammation Studies, and Oncology Studies. The Oncology Studies commanded largest market share of 27.35% in 2022, followed by Immunology & Inflammation Studies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 35.26% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Mice Model Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Mice Model Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Mice Model Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Mice Model Market?

4. What is the competitive strategic window for opportunities in the Global Mice Model Market?

5. What are the technology trends and regulatory frameworks in the Global Mice Model Market?

6. What is the market share of the leading vendors in the Global Mice Model Market?

7. What modes and strategic moves are considered suitable for entering the Global Mice Model Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Mice Model Market, by Service, 2022 vs 2030
• 4.3. Mice Model Market, by Type, 2022 vs 2030
• 4.4. Mice Model Market, by Technology, 2022 vs 2030
• 4.5. Mice Model Market, by Application, 2022 vs 2030
• 4.6. Mice Model Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Escalating use of mice models for drug testing and research of immune disease, cancer and rare disease
    • 5.1.1.2. Growing consumption of personalized medicine driving the demand for humanized mice models
    • 5.1.1.3. Rising investments and grants coupled with surging pharmaceutical R&D activities
  • 5.1.2. Restraints
    • 5.1.2.1. Associated limitations with mice models
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging implementation of AI and ML in mice modeling
    • 5.1.3.2. Improvements in non-invasive assessment of HFpEF in mouse model
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations and laws considering the ethical use of animals in research
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Mice Model Market, by Service

• 6.1. Introduction
• 6.2. Breeding
• 6.3. Cryopreservation
• 6.4. Genetic Testing
• 6.5. Model In-Licensing
• 6.6. Quarantine

7. Mice Model Market, by Type

• 7.1. Introduction
• 7.2. Conditioned/Surgically Modified Mice
• 7.3. Genetically Engineered Mice
• 7.4. Hybrid/Congenic Mice
• 7.5. Inbred Mice
• 7.6. Outbred Mice

8. Mice Model Market, by Technology

• 8.1. Introduction
• 8.2. CRISPER
• 8.3. Embryonic Stem Cell Injection
• 8.4. Genetically Modified Sperm-Mediated Gene Transfer
• 8.5. Liposome-Mediated DNA & Electroporation of DNA
• 8.6. Microinjection
• 8.7. Nuclear Transfer
• 8.8. TALENs & ZFNs

9. Mice Model Market, by Application

• 9.1. Introduction
• 9.2. Cardiovascular Studies
• 9.3. Central Nervous System Studies
• 9.4. Diabetes Studies
• 9.5. Immunology & Inflammation Studies
• 9.6. Oncology Studies

10. Americas Mice Model Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Mice Model Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Mice Model Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player
  • 13.3.1. New Product Launch & Enhancement
    • 13.3.1.1. Transgenic Mouse Models Show Jumping Genes
    • 13.3.1.2. NIH Scientists Advance Understanding Of Mpox Through Development Of Mouse Model
    • 13.3.1.3. Genetically Modified Mice Pave The Way For Customized Medicine In A Rare Disease
    • 13.3.1.4. A Mouse That Roars: Chinese Scientists Create The First Mammal With Fully Reprogrammed Genes
    • 13.3.1.5. New Method Of Pancreatic Islet Cryopreservation Is Major Breakthrough For Diabetes Cure
    • 13.3.1.6. UCLA Researchers Develop First Human Genomic Transgenic Mouse Model Of Huntington's Disease

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing